Enhancing the Efficacy and Bioavailability of Isoxsuprine for the Treatment of Cardiotoxicity: In vitro and In vivo Studies
{{output}}
Isoxsuprine (ISX) is a blood flow-improving beta-adrenergic agonist that provides cardiotoxicity protection. However, the limited effectiveness of ISX can be attributed to a short half-life and low bioavailability. The focus of this study was to create ISX-loa... ...
